BHUBANESWAR: Sapigen Biologix Private Limited has set up a large vaccine manufacturing unit at Biotech Park in Andharua on ...

Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar ...

“While oral cholera vaccination is important, it is one of several tools to curb the ongoing outbreak,” says Dr Humphrey ...

High-burden cholera outbreaks, spreading beyond the traditional cholera-endemic countries, have been reported since 2021 in ...

“WHO is at the forefront of the cholera response, with our teams working alongside the government health system for the early detection and timely management of cases. Our supplies are assisting a ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $18.00.Invest ...

From 1 January to 29 December 2024, a cumulative total of 804 721 cholera cases and 5805 deaths were reported from 33 countries across five WHO regions. The number of cases and deaths in December 2024 ...

Thirteen years of extended conflict, economic downturns, and multiple earthquakes, has left Syria in the midst of a severe humanitarian crisis. Hostilities remain abundant across all of Syria’s ...

The country also aims to lower the death rate from the disease to less than 1%. The Malawi Multi-sectoral Cholera Control ...

The number of suspected cases of Cholera recorded in the Agona West Municipality of the Central Region has risen to 214.

Kepler Capital analyst Justine Telliez maintained a Buy rating on Valneva (0OB3 – Research Report) on January 21 and set a price target of ...